Available in 5 mg and 10 mg vials, in lyophilized form.
TB-500 is a synthetic peptide corresponding to the actin-binding region of Thymosin beta-4, a naturally occurring 43-amino-acid peptide present in most mammalian cells and one of the principal intracellular actin-sequestering proteins.
Published research examines TB-500 in relation to G-actin sequestration and cytoskeletal dynamics, endothelial cell migration and angiogenesis, and extracellular matrix remodelling. Reported endpoints in animal models include myofibroblast density and fibrosis in wound healing preparations.
Areas of published research
- Re-epithelialisation rate and wound closure time in corneal and dermal models
- Capillary density and endothelial cell migration in angiogenesis assays
- Myofibroblast count and scar area as measures of fibrosis in wound healing preparations
- G-actin sequestration and cytoskeletal dynamics as the reported mechanism
For research use only. Not for human or veterinary use. Not a drug, food, or cosmetic.


Reviews
There are no reviews yet.